Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.
Hims & Hers expects revenue from its weight loss business to soar in 2025, even though a recent FDA move could make it ...
Super Micro has until Tuesday to file delayed financial accounts or risk being delisted by the Nasdaq stock exchange, Home ...
Bernstein analyst Florent Cespedes maintained a Hold rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK620.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback